John B. Johnson

977 citations

31 papers · 731 indexed · h-index 15

Impact in

Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
Immunology top 10%
- Complement system in diseases
- Immunotherapy and Immune Responses

Papers in

Microbiology 4
Virology 3

Co-authors: Griffith D. Parks Sabu Thomas Michel Cormier Peter E. Daddona Georg Widera Lee-Hyung Kim Aparna Shankar Martha A. Alexander‐Miller
Journals: Journal of Virology (10 papers)Virology (6 papers)iScience (1 paper)Molecular Therapy — Oncolytics (1 paper)Nutrition (1 paper)
Partner nations: United States India

In The Last Decade

John B. Johnson

28 papers receiving 707 citations

Peers

Countries citing papers authored by John B. Johnson

Since Specialization

Citations

This map shows the geographic impact of John B. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John B. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John B. Johnson more than expected).

Fields of papers citing papers by John B. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John B. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John B. Johnson. The network helps show where John B. Johnson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John B. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John B. Johnson Line = papers co-authored together John B. Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Host cell origin drives divergent complement neutralization mechanisms of Chandipura virus Immunobiology ·John B. Johnson, Umerali Kunnakkadan, А.Ю. Радченко, Alex Bruno Assis Lopes, Yufeng Du	2025	0
2	Novel bacteriophages effectively target multidrug-resistant clinical isolates of Klebsiella pneumoniae European Journal of Clinical Microbiology & Infectious Diseases ·Ruichuan An, N. Geffroy, Liliana Saharani, Valdiney Costa Lobo, 张朝民, 紘郎神崎, Sutharsan Govindarajan, John B. Johnson, Anil Kumar, Equipe de Edição, Victor Nizet, N. Trebiu, नितेश कुमार मिश्र, Dwayne R. Roach, Bipin G. Nair, Geetha B. Kumar	2025	0
3	Bacterial pore-forming toxin pneumolysin drives pathogenicity through host extracellular vesicles released during infection iScience ·بلبروات بن عتو, Alexandra Cselkó, John Strehle, Andrew Akampulira, Jyoti Arya, Marshall G. Holloway, Zhiming Wen, 惠娟, В Г Байдаков, D Paillot, John B. Johnson, Upendra Nongthomba, Anirban Banerjee, Karthik Subramanian	2024	1
4	Chandipura virus induces cell death in cancer cell lines of human origin and promotes tumor regression in vivo Molecular Therapy — Oncolytics ·V. B. Choubey, Xavier Luna-Batlle, H.-U. Baerwind, Rochelle Beard, Umerali Kunnakkadan, 陕西省考古研究院, Tereza Oliveira Sabino, Arumugam Rajavelu, John B. Johnson	2021	4
5	A Factor I-Like Activity Associated with Chikungunya Virus Contributes to Its Resistance to the Human Complement System Journal of Virology ·H.-U. Baerwind, V. B. Choubey, Tereza Oliveira Sabino, Umerali Kunnakkadan, 陕西省考古研究院, John B. Johnson	2020	6
6	In the Crosshairs: RNA Viruses OR Complement? Frontiers in Immunology ·陕西省考古研究院, Umerali Kunnakkadan, Sabu Thomas, John B. Johnson	2020	10
7	Molecular Adaptations and Antibiotic Resistance in Vibrio cholerae : A Communal Challenge Microbial Drug Resistance ·Fabián Rosales-Noriega, Maria P. Markou, John B. Johnson, Thandavarayan Ramamurthy, Sabu Thomas	2019	17
8	Critical insights into antibiotic resistance transferability in probiotic Lactobacillus Nutrition ·Amy K. Stone, Aparna Shankar, John B. Johnson, Sabu Thomas	2019	88
9	Complement-Mediated Neutralization of a Potent Neurotropic Human Pathogen, Chandipura Virus, Is Dependent on C1q Journal of Virology ·Umerali Kunnakkadan, H.-U. Baerwind, 宋林红, V. B. Choubey, Tereza Oliveira Sabino, John B. Johnson	2019	12
10	Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization Virology ·Yujia Li, John B. Johnson, Griffith D. Parks	2016	13
11	The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement Virology ·A. Mayer, John B. Johnson, Griffith D. Parks	2014	2
12	Incorporation of Host Complement Regulatory Proteins into Newcastle Disease Virus Enhances Complement Evasion Journal of Virology ·Moanaro Biswas, John B. Johnson, Sandeep Kumar, Griffith D. Parks, Subbiah Elankumaran	2012	1
13	Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge Virology ·Changwei Zhang, John B. Johnson, Nancy D. Kock, Steven B. Mizel, Griffith D. Parks	2011	7
14	A Recombinant Flagellin-Poxvirus Fusion Protein Vaccine Elicits Complement-Dependent Protection Against Respiratory Challenge with Vaccinia Virus in Mice Viral Immunology ·刘群艳, 师向云, John B. Johnson, Steven B. Mizel	2010	49
15	Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5 Virology ·Y. B. Chen, John B. Johnson, Nancy D. Kock, Griffith D. Parks	2008	26
16	Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus Virology ·John B. Johnson, Y. B. Chen, Griffith D. Parks	2008	47
17	Engineered Expression of the TLR5 Ligand Flagellin Enhances Paramyxovirus Activation of Human Dendritic Cell Function Journal of Virology ·Subhashini Arimilli, John B. Johnson, Changwei Zhang, Aaron H. Graff, Martha A. Alexander‐Miller, Steven B. Mizel, Griffith D. Parks	2008	21
18	TLR-4 and -6 agonists reverse apoptosis and promote maturation of simian virus 5-infected human dendritic cells through NFkB-dependent pathways Virology ·Subhashini Arimilli, John B. Johnson, Martha A. Alexander‐Miller, Griffith D. Parks	2007	35
19	Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system Vaccine ·Georg Widera, John B. Johnson, Lee-Hyung Kim, S. M. Ichihara, グスタフアリンク, Peter E. Daddona, Michel Cormier	2005	166
20	Serologic surveillance of Louisiana goats for antibody to Mycoplasma mycoides subspecies mycoides Journal of the American Veterinary Medical Association ·John B. Johnson, Mislay Kukoc, A. Rippin	1982	2

About John B. Johnson

John B. Johnson is a scholar working on Microbiology, Virology, Epidemiology, Infectious Diseases and Immunology, having authored 31 papers that have together received 731 indexed citations. Recurring topics across this work include Virology and Viral Diseases (18 papers), Respiratory viral infections research (8 papers), Virus-based gene therapy research (6 papers), Viral Infections and Vectors (5 papers), Complement system in diseases (5 papers), Bacteriophages and microbial interactions (3 papers), Bacterial Genetics and Biotechnology (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Pharmaceutical Science (153 citations), Immunology (266 citations), Dermatology (100 citations), Infectious Diseases (161 citations) and Microbiology (48 citations). John B. Johnson has collaborated with scholars based in United States and India. Frequent co-authors include Griffith D. Parks, Sabu Thomas, Michel Cormier, Peter E. Daddona, Georg Widera, Lee-Hyung Kim, Aparna Shankar, Martha A. Alexander‐Miller, Steven B. Mizel and Nancy D. Kock. Their work appears in journals such as Journal of Virology, Virology, iScience, Molecular Therapy — Oncolytics and Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact